Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Generalized Exanthematous Pustulosis
31%
Alopecia Areata
47%
Atopic Dermatitis
25%
Autosomal Recessive Congenital Ichthyosis
31%
Beta-blockers
17%
Cancer Prevention
17%
Cancer Screening
19%
CD11b
31%
CD24
47%
Clinical Data
28%
Clinical Efficacy
34%
Clinical Features
21%
Clinical Safety
19%
Dermatitis
17%
Drug Delivery System
21%
Effectiveness Evaluation
31%
Energy Devices
19%
Epidemiological Data
32%
Epidermolysis Bullosa
28%
Erythema
18%
Griseofulvin
33%
Incidence Rate
22%
Infantile Hemangioma
63%
Israel
27%
Israeli
35%
Melanoma
26%
Melanoma Patients
18%
Melasma
31%
Molluscum Contagiosum
18%
Non-syndromic
26%
Patch Test
25%
Pediatric
96%
Pemphigus
31%
Platelet-derived Growth factor-BB (PDGF-BB)
18%
Possible Mechanisms
19%
Propranolol
34%
Redness
35%
Refugee Population
18%
Response to Treatment
20%
Safety Profile
19%
Teenagers
20%
Tel Aviv
20%
Terbinafine
28%
Tinea Capitis
47%
Tixel
43%
Topical Application
20%
Treatment Data
26%
Treatment Modalities
23%
Treatment Options
35%
Vascular Endothelial Growth Factor
18%
Medicine and Dentistry
Acute Generalized Exanthematous Pustulosis
15%
Adverse Effect
18%
Albinism
31%
Angioleiomyoma
15%
Atopic Dermatitis
33%
Beta Adrenergic Receptor Blocking Agent
20%
Cancer
19%
Cancer Screening
19%
Capillary Hemangioma
63%
Chloasma
31%
Clinical Feature
17%
Clinician
18%
Cohort Effect
18%
Cutaneous Leishmaniasis
15%
Cytokinesis
15%
Depression Co Morbidities
15%
Dermatitis
20%
Dermatology
34%
Dermatosis
17%
Diseases
32%
Drug Delivery System
22%
Education
25%
Erythema
19%
Fluorouracil
15%
Griseofulvin
18%
Hematologic Malignancy
15%
Hypopigmentation
18%
Imiquimod
15%
Infection
16%
Melanoma
30%
Molluscum contagiosum
17%
Neurofibromatosis Type I
15%
Oral
22%
Patch Test
23%
Pathogenesis
35%
Pediatrics
100%
Pimecrolimus
15%
Platelet Derived Growth Factor
18%
Prevalence
19%
Propranolol
31%
Retrospective Study
30%
Screening Test
15%
Sodium Stibogluconate
15%
Tinea Capitis
31%
Topical Drug Administration
18%
Topical Treatment
19%
Treatment Modality
23%
Treatment Option
31%
Vasculotropin
18%
Wound Healing
15%